In 2021, there were 1,128 new biotech startup registrations in India, the highest in a single year since 2015, bringing the total number of biotechnology startups to 5,365. It is estimated that the number of startups will reach 10,000 by 2024. India has 665 FDA-approved plants in the US, accounting for 44% of the global abbreviated new drug applications (ANDA), and more than 1,400 manufacturing plants that are compliant with WHO's requirements. India is also the world's third-largest producer of recombinant Hepatitis B vaccine and the second-largest producer of BT cotton.